Stock SLRN ACELYRIN, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Acelyrin, Inc.

Equities

SLRN

US00445A1007

Market Closed - Nasdaq
Other stock markets
 21:00:00 23/05/2024 BST 		5-day change 1st Jan Change
4.22 USD -6.64% Intraday chart for Acelyrin, Inc. -10.97% -43.43%
05-22 HC Wainwright Adjusts Price Target on ACELYRIN to $18 From $16, Maintains Buy Rating MT
05-09 Acelyrin, Inc. Announces Ron Oyston to Step Down as Chief People Officer, Effective August 15, 2024 CI

Evolution of the average Target Price on Acelyrin, Inc.

Price target over the last 5 years

History of analyst recommendation changes

f0a6bfc6733b2b93aa.8cCAI_hUA_Z9qZ8VMBbEpKyu26njlrnxZe2sokSnrHo.h6vwYM0mLpAK4-9UBEKUlsjPuuu0-9GjApyf4yXi_j_EksNVqzphoi7g_A~149ebad189e575212898507877414b65

Analyst Recommendations on Acelyrin, Inc.

HC Wainwright Adjusts Price Target on ACELYRIN to $18 From $16, Maintains Buy Rating MT
Wells Fargo Raises ACELYRIN's Price Target to $13 From $11, Keeps Equalweight Rating MT
Wells Fargo Starts Coverage on ACELYRIN with Equalweight Rating, $11 Price Target MT
Citigroup Initiates ACELYRIN at Neutral Rating With $8 Price Target MT
Morgan Stanley Adjusts Price Target on ACELYRIN to $13 From $19, Maintains Equal-Weight Rating MT
Jefferies Adjusts ACELYRIN Price Target to $12 From $15, Maintains Buy Rating MT
Morgan Stanley Downgrades ACELYRIN to Equalweight From Overweight, Cuts Price Target to $19 From $39 MT
Morgan Stanley Adjusts Price Target on Acelyrin to $39 From $29, Maintains Overweight Rating MT
HC Wainwright Starts Acelyrin at Buy, $44 Price Target MT
Morgan Stanley Initiates Coverage on Acelyrin With Overweight Rating, $29 Price Target MT
Jefferies Starts Acelyrin at Buy With $31 Price Target MT
Piper Sandler Initiates Acelyrin at Overweight With $68 Price Target MT
TD Cowen Starts Acelyrin at Outperform MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
4.22 USD
Average target price
22.17 USD
Spread / Average Target
+425.28%
High Price Target
68 USD
Spread / Highest target
+1,511.37%
Low Price Target
8 USD
Spread / Lowest Target
+89.57%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Acelyrin, Inc.

HC Wainwright
Wells Fargo Securities
Citigroup
Morgan Stanley
Jefferies & Co.
TD Cowen
Piper Sandler

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. SLRN Stock
  4. Consensus Acelyrin, Inc.